AWARD
A -- Malaria Vaccine Research and Development Modification - Justification and Approval Document
- Notice Date
- 9/28/2016
- Notice Type
- Award Notice
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- Department of the Army, Army Contracting Command, ACC - APG (W911QY) Natick (SPS), BLDG 1 KANSAS ST, Natick, Massachusetts, 01760-5011, United States
- ZIP Code
- 01760-5011
- Solicitation Number
- W911QY-15-C-0076-P00006
- Archive Date
- 10/5/2016
- Point of Contact
- Shawn P. Haubner, Phone: 5082336167
- E-Mail Address
-
shawn.p.haubner.civ@mail.mil
(shawn.p.haubner.civ@mail.mil)
- Small Business Set-Aside
- N/A
- Award Number
- W911QY-15-C-0076-P00006
- Award Date
- 9/20/2016
- Awardee
- Sanaria Inc
- Award Amount
- $2,199,623.00
- Description
- Justification and Approval Document The U.S. Army Contracting Command, Aberdeen Proving Ground, Natick Contracting Division (NCD), on behalf of the Advanced Medical Development (AMD) Program Office of Naval Medical Research Center (NMRC), awarded a Modification to the W911QY-15-C-0076 contract on a sole source basis to Sanaria, Inc., to enhance and expand on the current scope for an improved manufacturing process of an irradiated sporozoites-based malaria vaccine to support large scale manufacturing for use in Phase 3 clinical trials. The requirement calls for the development of a large scale automated manufacturing process that is compliant with current Good Manufacturing Practices (cGMPs) that will produce larger amounts of malaria vaccine to be utilized in future Phase 3 clinical trials. The vaccine must utilize irradiated aseptic, purified, cryopreserved, attenuated (non-replicating), metabolically active Plasmodium falciparum (Pf) sporozoites (SPZ) extracted from mosquitos that are grown and incubated. In addition, the vaccine must be administered intravenously. Sanaria, Inc., a small business located in Rockville, MD is the only responsible source for this effort based on Market Research, and Sanaria, Inc. is the only vendor that is developing a malaria vaccine utilizing irradiated aseptic, purified, cryopreserved, attenuated (nonreplicating), metabolically active Plasmodium falciparum (Pf) sporozoites (SPZ) extracted from mosquitos that are grown and incubated. As such, this contract modification was awarded to Sanaria, Inc. The applicable NAICS code is 541711 with a size standard of 1000 employees.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/notices/21caee005152cc3c8c8f7c7f57af1767)
- Record
- SN04291537-W 20160930/160928235500-21caee005152cc3c8c8f7c7f57af1767 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |